PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
12-Jan-2024 BioInvent Regains Rights to Immuno-Oncology Targets from Exelixis AccessWire
11-Jan-2024 Cloud DX Signs 3 Contracts for Remote Patient Monitoring with Combined Value of approx. $375,000 CAD AccessWire
11-Jan-2024 WCH Franchise Revolutionizes Healthcare Services With First-of-Its-Kind Medical Billing Franchise AccessWire
11-Jan-2024 BioGX Expands PCR Test Menu at State Departments of Health AccessWire
11-Jan-2024 PRISM Vision Group Announces 25th Practice Affiliation AccessWire
11-Jan-2024 Newly Launched HearingLoss.com is Making Hearing Care More Accessible AccessWire
11-Jan-2024 CB Scientific, Inc. 2023 Year in Review AccessWire
11-Jan-2024 Mainz Biomed and TestDNA Drive CRC Innovation at the 10th Gdańsk Gastroenterology Symposium Mainz BioMed N.V.
11-Jan-2024 New Multi-Hospital Partner Joins OneMedNet's Expansive Real World Data Network AccessWire
11-Jan-2024 Halberd Corporation 2023 Year-End CEO Update and 2024 Goals AccessWire
11-Jan-2024 BD to Highlight its Deep Commitment to Drug Delivery Innovation at Pharmapack B3C newswire
11-Jan-2024 CGI and Tribun Health Selected to Lead Digital Pathology Transformation in Region Sjælland AccessWire
11-Jan-2024 Beauty-Stem Biomedical Teams Up With S.Y. Dao Cancer Prevention Foundation for Charitable Book Lecture on CD34 Stem Cells and Immunology AccessWire
10-Jan-2024 Fusion Launches Award Programs to Recognize Exceptional Healthcare Professionals AccessWire
10-Jan-2024 Burges Salmon advises Edinburgh-based biotech creation studio on £9m funding to support cancer research and accelerate treatment delivery Burges Salmon
10-Jan-2024 Pistoia Alliance Announces Dr Christian Baber as New Chief Portfolio Officer and Launches 2024 Project Pipeline The Pistoia Alliance
10-Jan-2024 Simris signs Head of Terms for an offtake agreement valued at minimum €2m / SEK 22m Simris Group AB (publ)
10-Jan-2024 Spago Nanomedical proceeds to the next dose level in the phase I/IIa study Tumorad-01 Spago Nanomedical AB (publ)
10-Jan-2024 University of Nottingham partnership sparks innovation in clean energy University of Nottingham
10-Jan-2024 Ariceum Therapeutics files for UK Clinical Trial Authorisation (CTA) to test its First-in-Class Iodine-123 labelled PARP inhibitor in patients with recurrent glioblastoma Ariceum Therapeutics